198 related articles for article (PubMed ID: 6261178)
1. Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro.
Lamberts SW; de Quijada M; Visser TJ
Neuroendocrinology; 1981 Mar; 32(3):150-4. PubMed ID: 6261178
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of Cushing's disease.
Fehm HL; Voigt KH
Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms.
Taylor AD; Cowell AM; Flower RJ; Buckingham JC
Neuroendocrinology; 1995 Nov; 62(5):530-42. PubMed ID: 8559285
[TBL] [Abstract][Full Text] [Related]
4. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
6. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
Suda T; Tomori N; Tozawa F; Demura H; Shizume K
J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
[TBL] [Abstract][Full Text] [Related]
7. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
8. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
9. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic regulation of basal versus thyrotropin-releasing hormone-induced prolactin secretion in rat anterior pituitary cells. differential roles of nitric oxide and intracellular calcium mobilization.
Pu HF; Tan SK; Chen HL; Jea JC; Liu TC
Neuroendocrinology; 1999 Nov; 70(5):324-31. PubMed ID: 10567858
[TBL] [Abstract][Full Text] [Related]
11. The pituitary ACTH, GH, LH, FSH, TSH and prolactin reserves in patients with Cushing's syndrome.
Hashimoto K
Endocrinol Jpn; 1975 Feb; 22(1):67-77. PubMed ID: 805044
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
13. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
[TBL] [Abstract][Full Text] [Related]
14. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin.
Re RN; Kourides IA; Ridgway EC; Weintraub BD; Maloof F
J Clin Endocrinol Metab; 1976 Aug; 43(2):338-46. PubMed ID: 820709
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
16. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
[TBL] [Abstract][Full Text] [Related]
17. Persistent GHRH-induced PRL secretion in Cushing's syndrome, obesity and exogenous hypercortisolism.
Cordido F; Peino R; Martínez-Ramonde T
Rev Esp Fisiol; 1994 Sep; 50(3):139-43. PubMed ID: 7886270
[TBL] [Abstract][Full Text] [Related]
18. Reserpine inhibits rat anterior pituitary hormone secretion in vitro: effects on prolactin and ACTH and ultrastructural observations.
Login IS; Cronin MJ; Lamberts SW; Valdenegro CA; MacLeod RM
Brain Res; 1983 Jan; 260(1):99-106. PubMed ID: 6297687
[TBL] [Abstract][Full Text] [Related]
19. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2000 May; 52(5):625-32. PubMed ID: 10792343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
